These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
109 related items for PubMed ID: 7773210
1. Influence of marrow CFU-GM content on engraftment and survival after allogeneic bone marrow transplantation. Bacigalupo A, Piaggio G, Podesta M, Figari O, Benvenuto F, Sogno G, Tedone E, Raffo MR, Grassia L, Ferrero R. Bone Marrow Transplant; 1995 Feb; 15(2):221-6. PubMed ID: 7773210 [Abstract] [Full Text] [Related]
2. Factors influencing the haematological recovery after allogeneic bone marrow transplantation in leukaemia patients treated with methotrexate-containing GVHD prophylaxis: a single-centre experience. Hassan HT, Krog C, Stockschläder M, Schleimer B, Zeller W, Krüger W, Erttmann R, Zander AR. Anticancer Res; 1997 Feb; 17(1B):589-99. PubMed ID: 9066585 [Abstract] [Full Text] [Related]
3. Bone marrow transplantation for chronic myeloid leukemia (CML) from unrelated and sibling donors: single center experience. Lamparelli T, Van Lint MT, Gualandi F, Occhini D, Barbanti M, Sacchi N, Ficai G, Ghinatti C, Ferrara GB, Delfino L, Pozzi S, Morabito A, Zikos P, Vitale V, Corvo R, Frassoni F, Bacigalupo A. Bone Marrow Transplant; 1997 Dec; 20(12):1057-62. PubMed ID: 9466278 [Abstract] [Full Text] [Related]
4. Alterations in both the hematopoietic microenvironment and the progenitor cell population follow the recovery from myeloablative therapy and bone marrow transplantation. Novitzky N, Mohamed R. Exp Hematol; 1995 Dec; 23(14):1661-6. PubMed ID: 8542962 [Abstract] [Full Text] [Related]
5. Recovery of CFU-GM from cryopreserved marrow and in vivo evaluation after autologous bone marrow transplantation are predictive of engraftment. Douay L, Gorin NC, Mary JY, Lemarie E, Lopez M, Najman A, Stachowiak J, Giarratana MC, Baillou C, Salmon C. Exp Hematol; 1986 Jun; 14(5):358-65. PubMed ID: 3519263 [Abstract] [Full Text] [Related]
6. Allogeneic peripheral blood stem cell transplantation in patients with early-phase hematologic malignancy: a retrospective comparison of short-term outcome with bone marrow transplantation. Lemoli RM, Bandini G, Leopardi G, Rosti G, Bonini A, Fortuna A, Rondelli D, Mangianti S, Motta MR, Rizzi S, Tassi C, Cavo M, Remiddi C, Curti A, Conte R, Tura S. Haematologica; 1998 Jan; 83(1):48-55. PubMed ID: 9542323 [Abstract] [Full Text] [Related]
7. Similar survival following HLA-identical sibling transplantation for standard indication in children with haematologic malignancies: a single center comparison of mobilized peripheral blood stem cell with bone marrow transplantation. Meisel R, Enczmann J, Balzer S, Bernbeck B, Kramm C, Schönberger S, Sinha K, Tröger A, Wernet P, Göbel U, Laws HJ, Dilloo D. Klin Padiatr; 2005 Jan; 217(3):135-41. PubMed ID: 15858704 [Abstract] [Full Text] [Related]
8. Allogeneic bone marrow or peripheral blood cell transplants in adults with hematologic malignancies: a single-center experience. Bacigalupo A, Zikos P, Van Lint MT, Valbonesi M, Lamparelli T, Gualandi F, Occhini D, Mordini N, Bregante S, Berisso G, Vitale V, Sessarego M, Marmont AM. Exp Hematol; 1998 May; 26(5):409-14. PubMed ID: 9590657 [Abstract] [Full Text] [Related]
9. Analysis of factors predicting speed of hematologic recovery after transplantation with 4-hydroperoxycyclophosphamide-purged autologous bone marrow grafts. Rowley SD, Piantadosi S, Marcellus DC, Jones RJ, Davidson NE, Davis JM, Kennedy J, Wiley JM, Wingard JR, Yeager AM. Bone Marrow Transplant; 1991 Mar; 7(3):183-91. PubMed ID: 2059755 [Abstract] [Full Text] [Related]
10. CD6+ T cell depleted allogeneic bone marrow transplantation from genotypically HLA nonidentical related donors. Soiffer RJ, Mauch P, Fairclough D, Alyea E, Anderson K, Fisher D, Freedman A, Bartlett-Pandite L, Robertson M, Schlossman R, Gollob J, Marcus K, Murray C, Kuhlman C, Freeman A, Nadler L, Ritz J. Biol Blood Marrow Transplant; 1997 Apr; 3(1):11-7. PubMed ID: 9209736 [Abstract] [Full Text] [Related]
11. Faster neutrophil and platelet engraftment, but no differences in acute GVHD or survival, using peripheral blood stem cells from related and unrelated donors, compared to bone marrow. Hägglund H, Ringdén O, Remberger M, Lönnqvist B, Sparrelid E, Tammik L, Kumlien G. Bone Marrow Transplant; 1998 Jul; 22(2):131-6. PubMed ID: 9707019 [Abstract] [Full Text] [Related]
12. Platelet engraftment in patients with hematologic malignancies following unmanipulated haploidentical blood and marrow transplantation: effects of CD34+ cell dose and disease status. Chang YJ, Xu LP, Liu DH, Liu KY, Han W, Chen YH, Yu-Wang, Chen H, Wang JZ, Zhang XH, Zhao XY, Huang XJ. Biol Blood Marrow Transplant; 2009 May; 15(5):632-8. PubMed ID: 19361756 [Abstract] [Full Text] [Related]
13. A low CD34+ cell dose results in higher mortality and poorer survival after blood or marrow stem cell transplantation from HLA-identical siblings: should 2 x 10(6) CD34+ cells/kg be considered the minimum threshold? Singhal S, Powles R, Treleaven J, Kulkarni S, Sirohi B, Horton C, Millar B, Shepherd V, Tait D, Saso R, Rowland A, Long S, Mehta J. Bone Marrow Transplant; 2000 Sep; 26(5):489-96. PubMed ID: 11019837 [Abstract] [Full Text] [Related]
14. The impact of CD34+ cell dose on platelet engraftment in pediatric patients following unmanipulated haploidentical blood and marrow transplantation. Chang YJ, Xu LP, Liu DH, Liu KY, Han W, Chen YH, Wang Y, Chen H, Wang JZ, Zhang XH, Zhao XY, Huang XJ. Pediatr Blood Cancer; 2009 Dec; 53(6):1100-6. PubMed ID: 19743519 [Abstract] [Full Text] [Related]
15. Deficient reconstitution of early progenitors after allogeneic bone marrow transplantation. Podestà M, Piaggio G, Frassoni F, Pitto A, Mordini N, Bregante S, Valeriani A, Bacigalupo A. Bone Marrow Transplant; 1997 May; 19(10):1011-7. PubMed ID: 9169645 [Abstract] [Full Text] [Related]
16. Long-term engraftment failure after marrow ablation and autologous hematopoietic reconstitution: differences between peripheral blood stem cell and bone marrow recipients. Bentley SA, Brecher ME, Powell E, Serody JS, Wiley JM, Shea TC. Bone Marrow Transplant; 1997 Mar; 19(6):557-63. PubMed ID: 9085735 [Abstract] [Full Text] [Related]
17. Influence of CD34(+) marrow cell dose on outcome of HLA-identical sibling allogeneic bone marrow transplants in patients with chronic myeloid leukaemia. Morariu-Zamfir R, Rocha V, Devergie A, Socié G, Ribaud P, Esperou H, Parquet N, Guardiola P, Dal Cortivo L, Bittencourt H, Garnier F, Traineau R, Marolleau JP, Chevret S, Gluckman E. Bone Marrow Transplant; 2001 Mar; 27(6):575-80. PubMed ID: 11319585 [Abstract] [Full Text] [Related]
18. Comparison of haematological recovery times and supportive care requirements of autologous recovery phase peripheral blood stem cell transplants, autologous bone marrow transplants and allogeneic bone marrow transplants. To LB, Roberts MM, Haylock DN, Dyson PG, Branford AL, Thorp D, Ho JQ, Dart GW, Horvath N, Davy ML. Bone Marrow Transplant; 1992 Apr; 9(4):277-84. PubMed ID: 1350938 [Abstract] [Full Text] [Related]
19. Factors affecting neutrophil and platelet reconstitution following T cell-depleted bone marrow transplantation: differential effects of growth factor type and role of CD34(+) cell dose. Keever-Taylor CA, Klein JP, Eastwood D, Bredeson C, Margolis DA, Burns WH, Vesole DH. Bone Marrow Transplant; 2001 Apr; 27(8):791-800. PubMed ID: 11477435 [Abstract] [Full Text] [Related]
20. Interleukin-3 followed by GM-CSF for delayed engraftment after autologous bone marrow transplantation. Crump M, Couture F, Kovacs M, Saragosa R, McCrae J, Brandwein J, Huebsch L, Beauregard-Zollinger L, Keating A. Exp Hematol; 1993 Mar; 21(3):405-410. PubMed ID: 8440338 [Abstract] [Full Text] [Related] Page: [Next] [New Search]